ASP Isotopes Inc. Common ...

NASDAQ: ASPI · Real-Time Price · USD
7.33
-0.23 (-3.04%)
At close: Jun 02, 2025, 3:59 PM
7.31
-0.20%
After-hours: Jun 02, 2025, 07:58 PM EDT

Company Description

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.

It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28.

The company also Uranium-235, an isotope of uranium for carbon-free energy industry.

ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. Common Stock logo
Country United States
IPO Date Nov 10, 2022
Industry Chemicals
Sector Basic Materials
Employees 136
CEO Paul Elliot Mann C.F.A.

Contact Details

Address:
433 Plaza Real
Washington, Florida
United States
Website aspisotopes.com

Stock Details

Ticker Symbol ASPI
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001921865
CUSIP Number 00218A105
ISIN Number US00218A1051
Employer ID 87-2618235
SIC Code 2890

Key Executives

Name Position
Dr. Gerdus Kemp M.D., Ph.D. Medical Director & Chief Executive Officer of Pet Labs
Paul Elliot Mann C.F.A. President, Chief Executive Officer & Executive Chairman
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. Chief Technology Officer
Heather Kiessling Chief Financial Officer
Robert Ainscow Chief Operating Officer
Dr. Xandra van Heerden Ph.D. Head of Research & Development
Hendrik T. van Wyk Head of Engineering
William Eden M.B.E. Global Head of HR & Director UK Nuclear Operations

Latest SEC Filings

Date Type Title
May 29, 2025 CB/A [Amend] Filing
May 29, 2025 8-K Current Report
May 28, 2025 8-K Current Report
May 27, 2025 8-K Current Report
May 22, 2025 8-K Current Report
May 22, 2025 CB/A [Amend] Filing
May 21, 2025 CB Filing
May 20, 2025 10-Q Quarterly Report
May 20, 2025 8-K Current Report
May 20, 2025 8-K Current Report